Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate.
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us...
Main Authors: | Timothy Caulfield, Jim Evans, Amy McGuire, Christopher McCabe, Tania Bubela, Robert Cook-Deegan, Jennifer Fishman, Stuart Hogarth, Fiona A Miller, Vardit Ravitsky, Barbara Biesecker, Pascal Borry, Mildred K Cho, June C Carroll, Holly Etchegary, Yann Joly, Kazuto Kato, Sandra Soo-Jin Lee, Karen Rothenberg, Pamela Sankar, Michael J Szego, Pilar Ossorio, Daryl Pullman, Francois Rousseau, Wendy J Ungar, Brenda Wilson |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-11-01
|
Series: | PLoS Biology |
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24223516/pdf/?tool=EBI |
Similar Items
-
Let’s do better: public representations of COVID-19 science
by: Timothy Caulfield, et al.
Published: (2021-03-01) -
La conciliation travail-famille : le défi des mères médecins
by: Johnson, Claude, et al.
Published: (2015-06-01) -
Neonatal screening for inborn errors of metabolism: cost, yield and outcome.
by: Pollitt, et al.
Published: (1997-01-01) -
Adherence and health care costs
by: Iuga AO, et al.
Published: (2014-02-01) -
Non-Invasive Prenatal Testing: Review of Ethical, Legal and Social Implications
by: Haidar, Hazar, et al.
Published: (2016-02-01)